510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

Rom Plus

K110605510(k) TraditionalCleared Nov 23, 2011266-day reviewClass I21 CFR 862.1550Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Clinical Innovations, LLC · NQM Immunoassay For Detection Of Amniotic Fluid Protein (S).

Cleared on Nov 23, 2011 as substantially equivalent to K030849 (N-Dia, Inc., 2004) and 4 other predicates after a 266-day review. Its family tree reaches back 2 generations to 2004. 1 of the 6 devices in its family, counting itself, has a Class I recall. It has been recalled once.

Decided
Nov 23, 2011
Review
266 days
Class
Class I
Product code
NQM
Recalls
1
Predicates
5

Its longest line of descent runs back 2 generations to K030849 (2004). 5 ancestors in all, the oldest K914419 (1993). No later device cites it as a predicate yet. 1 of the 6 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year cleared 2009: 1 other ancestor, 1 with a Class I recall12007: 1 other ancestor1993: 1 other ancestorK030849 · Amnisure Fetal Membranes Rupture Test Model FMRT1 · N-Dia, Inc. · 2004 · recalledK061886 · Actim Prom and Controls · Medix Biochemica · 200719901995200020052010
Other ancestors, by generation 1 generation back: 3 other ancestors, 1 with a Class I recall1 K061886 · Actim Prom and Controls · Medix Biochemica · 2007K030849 · Amnisure Fetal Membranes Rupture Test Model FMRT1 · N-Dia, Inc. · 2004 · recalled0
  1. Root · 2 generations backK030849 Amnisure Fetal Membranes Rupture Test Model FMRT1N-Dia, Inc. · 2004 · Recalled
  2. 1 generation backK061886 Actim Prom and ControlsMedix Biochemica · 2007
  3. This deviceK110605 Rom PlusClinical Innovations, LLC · 2011

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K030849Amnisure Fetal Membranes Rupture Test Model FMRT1N-Dia, Inc.20041
−1K061886Actim Prom and ControlsMedix Biochemica2007—
0 (this device)K110605Rom PlusClinical Innovations, LLC2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
200710
200911
FIG. 1 — Lineage of K110605, 2004–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K030849Amnisure Fetal Membranes Rupture Test Model FMRT1
Summary page 1
…y pH (Nonquantitative) Test System and Quality Control Material (Assayed and Unassayed) 3. Predicate Devices AmniSure ROM (Rupture Of [fetal] Membranes) Test N-Dia, Inc.-k030849, k08 1767 Actim Prom and Controls Medix Biochemica -k06 1886 AmnioTest (pH swab) -k914419 AmniScreen (pH liner) - k071 100 4. De…
N-Dia, Inc.20041
*K081767Amnisure Fetal Membranes Rupture Test, Model FMRT-1
Summary page 1
…quantitative) Test System and Quality Control Material (Assayed and Unassayed) 3. Predicate Devices AmniSure ROM (Rupture Of [fetal] Membranes) Test N-Dia, Inc.-k030849, k08 1767 Actim Prom and Controls Medix Biochemica -k06 1886 AmnioTest (pH swab) -k914419 AmniScreen (pH liner) - k071 100 4. Device Descr…
Amnisure International, LLC2009Class I
*K061886Actim Prom and Controls
Summary page 1
…ial (Assayed and Unassayed) 3. Predicate Devices AmniSure ROM (Rupture Of [fetal] Membranes) Test N-Dia, Inc.-k030849, k08 1767 Actim Prom and Controls Medix Biochemica -k06 1886 AmnioTest (pH swab) -k914419 AmniScreen (pH liner) - k071 100 4. Device Description The ROMPlus is a rapid test for detection of…
Medix Biochemica2007—
*K914419Amniotest (TM)
Summary page 1
…Predicate Devices AmniSure ROM (Rupture Of [fetal] Membranes) Test N-Dia, Inc.-k030849, k08 1767 Actim Prom and Controls Medix Biochemica -k06 1886 AmnioTest (pH swab) -k914419 AmniScreen (pH liner) - k071 100 4. Device Description The ROMPlus is a rapid test for detection of premature rupture of fetal m…
Pro-Lab, Inc.1993—
*K071100Amniscreen Home Detection Liner Kit
Summary page 1
…(Rupture Of [fetal] Membranes) Test N-Dia, Inc.-k030849, k08 1767 Actim Prom and Controls Medix Biochemica -k06 1886 AmnioTest (pH swab) -k914419 AmniScreen (pH liner) - k071 100 4. Device Description The ROMPlus is a rapid test for detection of premature rupture of fetal membranes. The test principle is l…
Common Sense, Ltd.2007—

Also cleared against K030849: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 13, 2020Class IIZ-0541-2021Process change controlPossible false negative or false positive results. The incorrect sample collection swabs (non-scored) were assembled into assembled into the in vitro diagnostic kits. If the user does not break the swab stick correctly, or if scissors or…

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K081767Amnisure Fetal Membranes Rupture Test, Model FMRT-1Amnisure International, LLC · 2009 · Direct predicate · ◆ in the 2009 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 4.8 years on median.
  • 2 of the 5 ancestors have a recall of any class; 1 has a Class I recall.
  • 1 other device also cites its predicate K030849.

How does its category compare?

All NQM devices

NQM Immunoassay For Detection Of Amniotic Fluid Protein (S).: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · NQM

1in 2011

2009: 12011: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQM

Too few NQM 510(k)s in any year since 2007 to give a median.

Recalls per year · NQM

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQM

1in 2025

2007: 12011: 72014: 52015: 32016: 12017: 32018: 72019: 52020: 52022: 12024: 12025: 1
2007high 7 (2011) · low 0 (2008)2025

MAUDE reports naming product code NQM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—00
20091—00
20100—00
20111—07
20120—00
20130—00
20140—05
20150—03
20160—01
20170—03
20180—07
20190—05
20200—15
20210—00
20220—01
20230—00
20240—01
20250—01
20260—0—

What is it indicated for?

The Clinical Innovations ROM Plus fetal membrane rupture test is a rapid, qualitative immunochromatographic test for the in-vitro detection of amniotic fluid in vaginal secretions of pregnant women with signs and symptoms of ROM. The test detects AFP (alpha-fetoprotein) and PPI12 (placental protein 12 or insulin growth factor binding protein) from amniotic fluid in vaginal secretion. The test is for prescription use by health care professionals to aid in…

Read the full statement (124 words)

The Clinical Innovations ROM Plus fetal membrane rupture test is a rapid, qualitative immunochromatographic test for the in-vitro detection of amniotic fluid in vaginal secretions of pregnant women with signs and symptoms of ROM. The test detects AFP (alpha-fetoprotein) and PPI12 (placental protein 12 or insulin growth factor binding protein) from amniotic fluid in vaginal secretion. The test is for prescription use by health care professionals to aid in the detection of rupture of membranes (ROM) in pregnant women in conjunction with other signs and symptoms.

The ROM Plus Quality Control Kit monitors the performance of the ROM Plus Fetal Membranes Rupture Test for the purposes of external quality control. The lyophilized human positive protein control is an assayed control material for qualitative testing.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110605: Rom Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110605

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026